|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | ||||||||||||||||||||
| Investments: | ||||||||||||||||||||
| Fixed maturities—available for sale, at fair value (amortized cost: 2026—$19,307,295; 2025—$18,820,464, allowance for credit losses: 2026— $3,297; 2025— $3,297) | ||||||||||||||||||||
| Mortgage loans | ||||||||||||||||||||
| Policy loans | ||||||||||||||||||||
| Other long-term investments (includes: 2026—$1,097,834; 2025—$1,109,719 under the fair value option) | ||||||||||||||||||||
| Short-term investments | ||||||||||||||||||||
| Total investments | ||||||||||||||||||||
| Cash | ||||||||||||||||||||
| Accrued investment income | ||||||||||||||||||||
| Other receivables | ||||||||||||||||||||
| Deferred acquisition costs | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Liabilities: | ||||||||||||||||||||
| Future policy benefits at current discount rates: (at original rates: 2023—$16,757,558; 2022—$16,306,870) | ||||||||||||||||||||
| Future policy benefits at current discount rates: (at original discount rates: 2026—$18,454,909; 2025—$18,129,506) | ||||||||||||||||||||
| Unearned and advance premium | ||||||||||||||||||||
| Policy claims and other benefits payable | ||||||||||||||||||||
| Other policyholders' funds | ||||||||||||||||||||
| Total policy liabilities | ||||||||||||||||||||
| Current and deferred income taxes | ||||||||||||||||||||
| Short-term debt | ||||||||||||||||||||
| Long-term debt (estimated fair value: 2026—$2,504,936; 2025—$2,225,320) | ||||||||||||||||||||
| Other liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Shareholders' equity: | ||||||||||||||||||||
| Preferred stock, par value $1 per share—5,000,000 shares authorized; outstanding: 0 in 2026 and 2025 | ||||||||||||||||||||
| Common stock, par value $1 per share—320,000,000 shares authorized; outstanding: (2026—92,218,183 issued; 2025—92,218,183 issued) | ||||||||||||||||||||
| Additional paid-in-capital | ||||||||||||||||||||
| Accumulated other comprehensive income (loss) | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Treasury stock, at cost: (2026—15,164,175 shares; 2025—13,125,082 shares) | ||||||||||||||||||||
| Total shareholders' equity | ||||||||||||||||||||
| Total liabilities and shareholders' equity | ||||||||||||||||||||
Loading...
